14.30-14.40 | Welcome and Introduction A. Castagna, M. Santoro, M. Zazzi |
14.40-15.10 | Lecture: BnABS for HIV management and cure S. Deeks |
15.10-15.30 | Discussants: G.C. Marchetti, S. Rusconi |
15.30-16.00 | Lecture: Pharmacology of new drugs S. Bonora |
16.00-16.20 | Discussants: A.M. Cattelan, G. Cenderello |
Coffee break in sala | |
Moderators: A. Calcagno, G. Guaraldi | |
16.20-16.50 | Towards early screening of comorbidities A. Di Biagio |
16.50-17.30 | Going to the RING: Comorbidities L. Calza, A. Cervo, G.V. De Socio, R. Papaioannu Borjesson |
17.30-18.40 | The PRESTIGIO Registry: where are we? A. Castagna Discussants: All Steering Committee Members |
18.40-19.00 | Closing remarks A. Castagna, M. Santoro, M. Zazzi |
Moderators: A. Castagna, M. Santoro, M. Zazzi | |
09.00-09.30 | Lecture: Low level viremia meaning and management A.M.J. Wensing |
09.30-09.50 | Discussants: M. Santoro, M. Zazzi |
09.50-10.30 | Going to the RING: Low level viremia T. Clemente, M. Compagno, R. Gagliardini, A. Giacomelli |
10.30-11.10 | Phenotypic Resistance testing: to be or not to be? F. Saladini |
11.10-12.00 | Going to the RING: Phenotype or Genotype? M. Fabbiani, E. FocĂ , F. Lagi |
Coffee break in sala | |
Moderators: S. Rusconi, M. Santoro | |
12.00-12.20 | NGS and Whole genome sequencing (WGS): the cut-off dilemma D. Armenia |
12.20-13.00 | Going to the RING : NGS L. Comi, M. Fiscon, M. Mazzitelli, P.F. Salvo |
13.00-14.00 | Light lunch |
14.00-14.45 | 2024-2025 PRESTIGIO Research Proposals V. Spagnuolo Discussants: all |
14.45-15.30 | PRESTIGIO Q&A (e-CRF, biological samples collection, others) E. Carini, A. Galli, R. Lolatto |
15.30-16.00 | Take-home messages and closing remarks A. Castagna, M. Santoro, M. Zazzi |